PACIRA BIOSCIENCES, INC. Acquisitions, Net of Cash Acquired
PACIRA BIOSCIENCES, INC. (PCRX) reported Acquisitions, Net of Cash Acquired of $335.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-08-04
- PACIRA BIOSCIENCES, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2026-06-30 was $0.00.
- PACIRA BIOSCIENCES, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2026-03-31 was $335.00K, a 97.99% decline year-over-year.
- PACIRA BIOSCIENCES, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2025-12-31 was $0.00.
- PACIRA BIOSCIENCES, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2025-09-30 was $0.00.
- PACIRA BIOSCIENCES, INC. payments to acquire businesses, net of cash acquired for fiscal 2025 was $16.70M.
- PACIRA BIOSCIENCES, INC. payments to acquire businesses, net of cash acquired for fiscal 2024 was $0.00.
- PACIRA BIOSCIENCES, INC. payments to acquire businesses, net of cash acquired for fiscal 2023 was $0.00.
- PACIRA BIOSCIENCES, INC. payments to acquire businesses, net of cash acquired for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 1 month | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $335.00K 10-Q · filed 2026-08-04 | $335.00K derived: sum of 3 quarters · filed 2026-08-04 | $335.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2026-03-31 | $335.00K 10-Q · filed 2026-04-30 | $335.00K derived: sum of 2 quarters · filed 2026-04-30 | $335.00K derived: sum of 3 quarters · filed 2026-04-30 | $335.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | $16.70M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-04 | $16.70M 10-Q · filed 2025-11-06 | $16.70M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $16.70M 10-Q · filed 2026-08-04 | $16.70M derived: sum of 3 quarters · filed 2026-08-04 | $16.70M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-31 | $16.70M 10-Q · filed 2026-04-30 | $16.70M derived: sum of 2 quarters · filed 2026-04-30 | $16.70M derived: sum of 3 quarters · filed 2026-04-30 | $16.70M derived: sum of 4 quarters · filed 2026-04-30 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | |||||
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 | |||||
| 2022-12-31 | $0.00 10-K · filed 2024-02-29 | |||||
| 2021-12-31 | $420.04M 10-K · filed 2024-02-29 | $0.00 10-K · filed 2022-02-28 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $0.00 10-Q · filed 2020-10-30 | ||||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 | |||||
| 2019-12-31 | -$992.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$992.00K derived: sum of 2 quarters · filed 2022-02-28 | $117.69M 10-K · filed 2022-02-28 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $118.68M 10-Q · filed 2020-10-30 | ||||
| 2019-06-30 | $118.68M 10-Q · filed 2020-08-06 | |||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $0.00 10-Q · filed 2019-11-08 | ||||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-08 | |||||
| 2017-12-31 | $0.00 10-K · filed 2020-02-21 | |||||
| 2017-10-31 | $15.00M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |